On comparing outcomes at the end of 180 days between patients with possible CAM‐DILI and prescription‐drug‐related ACLF, mortality was found to be higher among patients in the CAM‐DILI cohort (50% versus 28%), but this did not reach statistical significance (Fig. 6 ).
← all excerpts
A Single-Center Experience on Outcomes of Complementary and Alternative Medicine Use Among Patients With Cirrhosis.
1
—
—